Excitatory amino acid receptor antagonists: A novel treatment for ischemic cerebrovascular diseases
- 1 January 1994
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 55 (25-26) , 2115-2124
- https://doi.org/10.1016/0024-3205(94)00392-0
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat.Stroke, 1992
- N-Methyl-D-Aspartate Receptor Antagonists: A Novel Therapeutic Perspective for the Treatment of Ischemic Brain InjuryCerebrovascular Diseases, 1991
- Glutamate dysfunction and selective motor neuron degeneration inamyotrophic lateral sclerosis: A hypothesisAnnals of Neurology, 1990
- Abnormalities of Striatal Projection Neurons andN-Methyl-D-Aspartate Receptors in Presymptomatic Huntington's DiseaseNew England Journal of Medicine, 1990
- Dynamics of Extracellular Metabolites in the Striatum after Middle Cerebral Artery Occlusion in the Rat Monitored by Intracerebral MicrodialysisJournal of Cerebral Blood Flow & Metabolism, 1989
- Excitatory amino acids and Alzheimer's diseaseNeurobiology of Aging, 1989
- N‐methyl‐D‐aspartate antagonists: Ready for clinical trial in brain ischemia?Annals of Neurology, 1989
- Ionic dependence of glutamate neurotoxicityJournal of Neuroscience, 1987
- Glutamate and the pathophysiology of hypoxic–ischemic brain damageAnnals of Neurology, 1986
- Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral MicrodialysisJournal of Neurochemistry, 1984